225 related articles for article (PubMed ID: 15056723)
1. Methamphetamine increases dopamine transporter higher molecular weight complex formation via a dopamine- and hyperthermia-associated mechanism.
Baucum AJ; Rau KS; Riddle EL; Hanson GR; Fleckenstein AE
J Neurosci; 2004 Mar; 24(13):3436-43. PubMed ID: 15056723
[TBL] [Abstract][Full Text] [Related]
2. Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicity.
Hansen JP; Riddle EL; Sandoval V; Brown JM; Gibb JW; Hanson GR; Fleckenstein AE
J Pharmacol Exp Ther; 2002 Mar; 300(3):1093-100. PubMed ID: 11861820
[TBL] [Abstract][Full Text] [Related]
3. Methamphetamine-induced rapid decrease in dopamine transporter function: role of dopamine and hyperthermia.
Metzger RR; Haughey HM; Wilkins DG; Gibb JW; Hanson GR; Fleckenstein AE
J Pharmacol Exp Ther; 2000 Dec; 295(3):1077-85. PubMed ID: 11082443
[TBL] [Abstract][Full Text] [Related]
4. Methamphetamine-induced dopamine transporter complex formation and dopaminergic deficits: the role of D2 receptor activation.
Hadlock GC; Chu PW; Walters ET; Hanson GR; Fleckenstein AE
J Pharmacol Exp Ther; 2010 Oct; 335(1):207-12. PubMed ID: 20622144
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms underlying methamphetamine-induced dopamine transporter complex formation.
Hadlock GC; Baucum AJ; King JL; Horner KA; Cook GA; Gibb JW; Wilkins DG; Hanson GR; Fleckenstein AE
J Pharmacol Exp Ther; 2009 Apr; 329(1):169-74. PubMed ID: 19141713
[TBL] [Abstract][Full Text] [Related]
6. The effects of methamphetamine on serotonin transporter activity: role of dopamine and hyperthermia.
Haughey HM; Fleckenstein AE; Metzger RR; Hanson GR
J Neurochem; 2000 Oct; 75(4):1608-17. PubMed ID: 10987842
[TBL] [Abstract][Full Text] [Related]
7. Methamphetamine self-administration causes persistent striatal dopaminergic alterations and mitigates the deficits caused by a subsequent methamphetamine exposure.
McFadden LM; Hadlock GC; Allen SC; Vieira-Brock PL; Stout KA; Ellis JD; Hoonakker AJ; Andrenyak DM; Nielsen SM; Wilkins DG; Hanson GR; Fleckenstein AE
J Pharmacol Exp Ther; 2012 Feb; 340(2):295-303. PubMed ID: 22034657
[TBL] [Abstract][Full Text] [Related]
8. Rapid and reversible effects of methamphetamine on dopamine transporters.
Fleckenstein AE; Metzger RR; Wilkins DG; Gibb JW; Hanson GR
J Pharmacol Exp Ther; 1997 Aug; 282(2):834-8. PubMed ID: 9262348
[TBL] [Abstract][Full Text] [Related]
9. Methamphetamine-induced rapid and reversible changes in dopamine transporter function: an in vitro model.
Sandoval V; Riddle EL; Ugarte YV; Hanson GR; Fleckenstein AE
J Neurosci; 2001 Feb; 21(4):1413-9. PubMed ID: 11160413
[TBL] [Abstract][Full Text] [Related]
10. Single and binge methamphetamine administrations have different effects on the levels of dopamine D2 autoreceptor and dopamine transporter in rat striatum.
Chauhan H; Killinger BA; Miller CV; Moszczynska A
Int J Mol Sci; 2014 Apr; 15(4):5884-906. PubMed ID: 24717411
[TBL] [Abstract][Full Text] [Related]
11. Preclinical evaluation of GBR12909 decanoate as a long-acting medication for methamphetamine dependence.
Baumann MH; Phillips JM; Ayestas MA; Ali SF; Rice KC; Rothman RB
Ann N Y Acad Sci; 2002 Jun; 965():92-108. PubMed ID: 12105088
[TBL] [Abstract][Full Text] [Related]
12. Different glial response to methamphetamine- and methylenedioxymethamphetamine-induced neurotoxicity.
Pubill D; Canudas AM; Pallàs M; Camins A; Camarasa J; Escubedo E
Naunyn Schmiedebergs Arch Pharmacol; 2003 May; 367(5):490-9. PubMed ID: 12684743
[TBL] [Abstract][Full Text] [Related]
13. Effects of subchronic methamphetamine exposure on basal dopamine and stress-induced dopamine release in the nucleus accumbens shell of rats.
Broom SL; Yamamoto BK
Psychopharmacology (Berl); 2005 Sep; 181(3):467-76. PubMed ID: 15986185
[TBL] [Abstract][Full Text] [Related]
14. Age-dependent differential responses of monoaminergic systems to high doses of methamphetamine.
Kokoshka JM; Fleckenstein AE; Wilkins DG; Hanson GR
J Neurochem; 2000 Nov; 75(5):2095-102. PubMed ID: 11032899
[TBL] [Abstract][Full Text] [Related]
15. Effect of temperature on dopamine transporter function and intracellular accumulation of methamphetamine: implications for methamphetamine-induced dopaminergic neurotoxicity.
Xie T; McCann UD; Kim S; Yuan J; Ricaurte GA
J Neurosci; 2000 Oct; 20(20):7838-45. PubMed ID: 11027249
[TBL] [Abstract][Full Text] [Related]
16. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine.
Bjorklund NL; Sorg BA; Schenk JO
Synapse; 2008 Oct; 62(10):736-45. PubMed ID: 18651643
[TBL] [Abstract][Full Text] [Related]
17. Methamphetamine-induced alterations in dopamine transporter function.
Bennett BA; Hollingsworth CK; Martin RS; Harp JJ
Brain Res; 1998 Jan; 782(1-2):219-27. PubMed ID: 9519266
[TBL] [Abstract][Full Text] [Related]
18. Prior methamphetamine self-administration attenuates the dopaminergic deficits caused by a subsequent methamphetamine exposure.
McFadden LM; Vieira-Brock PL; Hanson GR; Fleckenstein AE
Neuropharmacology; 2015 Jun; 93():146-54. PubMed ID: 25645392
[TBL] [Abstract][Full Text] [Related]
19. Bupropion increases striatal vesicular monoamine transport.
Rau KS; Birdsall E; Hanson JE; Johnson-Davis KL; Carroll FI; Wilkins DG; Gibb JW; Hanson GR; Fleckenstein AE
Neuropharmacology; 2005 Nov; 49(6):820-30. PubMed ID: 16005476
[TBL] [Abstract][Full Text] [Related]
20. Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter.
Fumagalli F; Gainetdinov RR; Valenzano KJ; Caron MG
J Neurosci; 1998 Jul; 18(13):4861-9. PubMed ID: 9634552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
